In 2024 and as of 30 of April, approximately 240 000 CHIKVD cases and over 90 deaths have been reported worldwide. A total of 18 countries reported CHIKVD cases from the Americas (11), Asia (6), and Africa (1).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 25-31 May 2024 and includes updates on avian influenza, respiratory viruses, invasive meningococcal disease, mass gatherings for Hajj in Saudi Arabia, cholera, chikungunya, dengue, and poliomyelitis.
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of chikungunya in its weekly threat report (Communicable Diseases Threat Report).
On 31 May 2024, the European Medicines Agency (EMA) published the Committee for Medicinal Products for Human Use (CHMP) reflection paper on Creutzfeldt-Jakob disease (CJD) and plasma-derived and urine-derived medicinal products.
This framework describes the building blocks and actions that ECDC will use to support and EU/EEA countries and the European Commission to achieve the Sustainable Development Goal (SDG).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-25 May 2024 and includes updates on respiratory virus epidemiology in the EU/EEA, influenza, avian influenza, and cholera.
From 22-23 May a team of experts from ECDC, the Directorate-General for Health and Food Safety and the European Food Safety Authority completed a visit to Kosovo to support the country’s efforts to develop the One Health Country Roadmap on antimicrobial resistance.
Delegates from the Western Balkans and Turkey, alongside representatives from the Africa CDC and MediPIET, were active participants in this year's ECDC Summer School, held from 22 – 24 May in Stockholm, Sweden.
On 15 and 16 May 2024, staff from the European Centre of Disease Prevention and Control (ECDC) visited the National Agency for Public Health (ANSP) in Moldova to assess its capacity as a training site for the MediPIET programme.